phase readout
saveNCT07622186: A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
NOT_YET_RECRUITINGupdated 22m ago
community read0 votes
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that